|The dielectric properties of biological tissues: II. Measurements in the frequency range 10 Hz to 20 GHz|
S Gabriel, RW Lau, C Gabriel
Physics in medicine & biology 41 (11), 2251, 1996
|Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or …|
JD Bradley, R Paulus, R Komaki, G Masters, G Blumenschein, S Schild, ...
The lancet oncology 16 (2), 187-199, 2015
|A large-scale study of the ultrawideband microwave dielectric properties of normal, benign and malignant breast tissues obtained from cancer surgeries|
M Lazebnik, D Popovic, L McCartney, CB Watkins, MJ Lindstrom, J Harter, ...
Physics in medicine & biology 52 (20), 6093, 2007
|A large-scale study of the ultrawideband microwave dielectric properties of normal breast tissue obtained from reduction surgeries|
M Lazebnik, L McCartney, D Popovic, CB Watkins, MJ Lindstrom, J Harter, ...
Physics in medicine & biology 52 (10), 2637, 2007
|Type I and II endometrial cancers: have they different risk factors?|
VW Setiawan, HP Yang, MC Pike, SE McCann, H Yu, YB Xiang, A Wolk, ...
Journal of Clinical Oncology 31 (20), 2607, 2013
|Comprehensive and integrated genomic characterization of adult soft tissue sarcomas|
AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ...
Cell 171 (4), 950-965, 2017
|Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG 1406).|
S Kopetz, SL McDonough, VK Morris, HJ Lenz, AM Magliocco, CE Atreya, ...
Journal of Clinical Oncology 35 (4_suppl), 520-520, 2017
|Suppression of ING1 expression in sporadic breast cancer|
T Toyama, H Iwase, P Watson, H Muzik, E Saettler, A Magliocco, ...
Oncogene 18 (37), 5187-5193, 1999
|An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging|
S Drabycz, G Roldán, P De Robles, D Adler, JB McIntyre, AM Magliocco, ...
Neuroimage 49 (2), 1398-1405, 2010
|Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model|
WH Roa, S Azarmi, MHDK Al-Hallak, WH Finlay, AM Magliocco, ...
Journal of controlled release 150 (1), 49-55, 2011
|Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme|
AE Sijben, JB McIntyre, GB Roldán, JC Easaw, E Yan, PA Forsyth, ...
Journal of neuro-oncology 89 (1), 97-103, 2008
|A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors|
LM Kmet, LS Cook, AM Magliocco
Cancer 97 (2), 389-404, 2003
|Case–control study of the metabolic syndrome and metabolic risk factors for endometrial cancer|
CM Friedenreich, RK Biel, DCW Lau, I Csizmadi, KS Courneya, ...
Cancer Epidemiology and Prevention Biomarkers 20 (11), 2384-2395, 2011
|Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53|
CT Williamson, E Kubota, JD Hamill, A Klimowicz, R Ye, H Muzik, M Dean, ...
EMBO molecular medicine 4 (6), 515-527, 2012
|Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas|
LA Brown, J Irving, R Parker, H Kim, JZ Press, TA Longacre, S Chia, ...
Gynecologic oncology 100 (2), 264-270, 2006
|Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03|
QT Le, J Harris, AM Magliocco, CS Kong, R Diaz, B Shin, H Cao, A Trotti, ...
Journal of Clinical Oncology 27 (26), 4281, 2009
|Molecular mechanisms of hepatic metastasis in colorectal cancer|
LR Rudmik, AM Magliocco
Journal of surgical oncology 92 (4), 347-359, 2005
|Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeutic|
CM Thirukkumaran, MJ Nodwell, K Hirasawa, ZQ Shi, R Diaz, J Luider, ...
Cancer research 70 (6), 2435-2444, 2010
|Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure|
AR Peck, AK Witkiewicz, C Liu, GA Stringer, AC Klimowicz, E Pequignot, ...
Journal of clinical oncology 29 (18), 2448, 2011
|PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy|
JB McIntyre, JS Wu, PS Craighead, T Phan, M Köbel, SP Lees-Miller, ...
Gynecologic oncology 128 (3), 409-414, 2013